Pharmacy- Page 35

Roche ranked the most sustainable healthcare company in the DJSI

November 16, 2020

Pharmacy

The FINANCIAL — For the eleventh time, Roche has been recognised as the most sustainable company in the Pharmaceuticals index of the Dow Jones Sustainability Indices (DJSI). This is based on an in-depth analysis of economic, social and environmental performance. The DJSI family of indices serves as a benchmark for investors who integrate sustainability considerations into their portfolios. Roche has

Gilead and Novo Nordisk announced new data from proof-of-concept trial in NASH

The FINANCIAL — Gilead Sciences, Inc. and Novo Nordisk A/S announced results

by The FINANCIAL

November 16, 2020

2 mins read

Metagenomi closes USD 65 million Series A financing led by Leaps by Bayer and Humboldt Fund

The FINANCIAL — Metagenomi, a next generation gene editing company launched by

by The FINANCIAL

November 12, 2020

1 min read

Pharmaceutical industries join to promise fair access to COVID-19 medicines and vaccines

The FINANCIAL — On the occasion of the World Health Assembly, the world’s

by The FINANCIAL

November 12, 2020

1 min read

Pharmacy

Takeda and Seattle Genetics Report Positive Phase 3 ALCANZA Clinical Trial Data of ADCETRIS

The FINANCIAL -- Takeda Pharmaceutical Company Limited and Seattle Genetics, Inc. on December 4 announced that data from the Phase 3 ALCANZA clinical trial evaluating ADCETRIS (brentuximab vedotin) in patients with cutaneous T-cell lymphoma (CTCL) will be presented in an oral session

by The FINANCIAL

December 5, 2016

5 mins read

Pharmacy

AstraZeneca completes agreement With Cilag GmbH International for rights to Rhinocort Aqua outside the US

The FINANCIAL -- AstraZeneca on December 5 announced that it has completed the agreement with Cilag GmbH International, an affiliate of Johnson & Johnson, for the divestment of the rights to Rhinocort Aqua outside the US. Rhinocort Aqua is a nasal spray

by The FINANCIAL

December 5, 2016

1 min read

Pharmacy

Changes in Roche Board of Directors

The FINANCIAL -- At its December meeting, the Board of Directors (BoD) of Roche Holding decided on first proposals for approval by the Annual General Meeting (AGM), scheduled for 14 March 2017.

by The FINANCIAL

December 5, 2016

1 min read

Pharmacy

LYRICA (pregabalin) Phase 3 Trial in Pediatric Epilepsy Meets Primary Endpoint

The FINANCIAL -- Pfizer Inc. announced on December 1 positive top-line results of a study that evaluated the use of LYRICA (pregabalin) Capsules CV and Oral Solution CV as adjunctive therapy for pediatric epilepsy patients four to 16 years of age with

by The FINANCIAL

December 2, 2016

1 min read

Pharmacy

Relvar Ellipta 100/25 mcg gains approval in Japan for use in patients with COPD

The FINANCIAL -- GlaxoSmithKline plc on December 2 announced that the Japanese Ministry of Health, Labour and Welfare (MHLW) has approved Relvar Ellipta (fluticasone furoate / vilanterol 100/25 mcg) for the relief of various symptoms with chronic obstructive pulmonary disease (chronic bronchitis,

by The FINANCIAL

December 2, 2016

1 min read

Pharmacy

Novartis Access shares one-year learnings and announces memorandum of understanding with Rwanda

The FINANCIAL -- Novartis announced on November 29 that Rwanda is the third country to sign a memorandum of understanding with Novartis Access after Kenya and Ethiopia.

by The FINANCIAL

November 29, 2016

2 mins read

Pharmacy

IFPMA head announces departure

The FINANCIAL -- After seven years as Director General, Eduardo Pisani announced on November 23 his decision to leave the International Federation of Pharmaceutical Manufacturers and Associations (IFPMA), representing the leading research-based biopharmaceutical companies as well as national and regional industry associations

by The FINANCIAL

November 24, 2016

1 min read

Pharmacy

NINLARO (ixazomib）Receives Conditional Approval from the European Commission to Treat Multiple Myeloma

The FINANCIAL -- Takeda Pharmaceutical Company Limited on November 24 announced that the European Commission has granted conditional marketing authorization for NINLARO （ixazomib） capsules, indicated in combination with lenalidomide and dexamethasone for adult patients with multiple myeloma who have received at least

by The FINANCIAL

November 24, 2016

2 mins read

Pharmacy

Anthony J. Maddaluna, Executive Vice President and President of Pfizer Global Supply to Retire

The FINANCIAL -- Pfizer Inc. on November 21 announced that Anthony J. Maddaluna, Executive Vice President and President of Pfizer Global Supply will retire from the company after more than 41 years with Pfizer.

by The FINANCIAL

November 22, 2016

1 min read

Pharmacy

Teva Secures European Approval of Trisenox for First Line Treatment of Low to Intermediate Risk Acute Promyelocytic Leukemia

The FINANCIAL -- Teva Pharmaceutical Industries Ltd., on November 21 announced it has obtained approval from the European Commission for an indication extension of Trisenox (arsenic trioxide).

by The FINANCIAL

November 21, 2016

1 min read

Previous 1 … 33 34 35 36 37 … 195 Next

Pharmacy- Page 35

Roche ranked the most sustainable healthcare company in the DJSI

Gilead and Novo Nordisk announced new data from proof-of-concept trial in NASH

Metagenomi closes USD 65 million Series A financing led by Leaps by Bayer and Humboldt Fund

Pharmaceutical industries join to promise fair access to COVID-19 medicines and vaccines

Takeda and Seattle Genetics Report Positive Phase 3 ALCANZA Clinical Trial Data of ADCETRIS

AstraZeneca completes agreement With Cilag GmbH International for rights to Rhinocort Aqua outside the US

Changes in Roche Board of Directors

LYRICA (pregabalin) Phase 3 Trial in Pediatric Epilepsy Meets Primary Endpoint

Relvar Ellipta 100/25 mcg gains approval in Japan for use in patients with COPD

Novartis Access shares one-year learnings and announces memorandum of understanding with Rwanda

IFPMA head announces departure

NINLARO (ixazomib）Receives Conditional Approval from the European Commission to Treat Multiple Myeloma

Anthony J. Maddaluna, Executive Vice President and President of Pfizer Global Supply to Retire

Teva Secures European Approval of Trisenox for First Line Treatment of Low to Intermediate Risk Acute Promyelocytic Leukemia

Popular Posts

Natali Safaryan – The Voice of Armenia on the International Stage

We Are Proud of Every Jury Member”: Mykyta Harmel and the Global Mission of Golden Time Talent

By 41% to 30% public say government right to u-turn on welfare

Sean Combs Trial: A High-Profile Case Ends in Mixed Verdict, Exposing Prosecutorial Missteps

International Festival of Arts and Talents in London: World Talent Award 2025

Modern bathroom that you will be proud of having it

Artificial intelligence powers record-breaking all-in-one miniature spectrometers

Poverty rate in India was slashed, says report, but globally 1.2bn still poor

Food industry shows ‘stalled progress’ to reduce salt intakes

Depressed people are just more realistic, right? Not so, says UC Berkeley study

Recent Posts

Get updates

Join

Latest comments

Suggestions

Pharmacy- Page 35

Popular Posts

Recent Posts

Get updates

Join

Latest comments